4.8 Article

Encapsulated stem cell-derived β cells exert glucose control in patients with type 1 diabetes

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Endocrinology & Metabolism

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

Tadej Battelino et al.

Summary: Randomised controlled trials and other prospective clinical studies have traditionally used HbA1c as a measure of average blood glucose levels, but with the increasing use of continuous glucose monitoring (CGM), CGM-derived metrics are being considered for use in these studies. This consensus statement recommends the use of CGM data in clinical studies to provide additional clinical information beyond HbA1c. Standardizing the collection and reporting of CGM data in clinical trials can enhance the interpretability of the data and inform therapeutic decisions related to hypoglycaemia, postprandial hyperglycaemia, and glucose variability.

LANCET DIABETES & ENDOCRINOLOGY (2023)

Article Endocrinology & Metabolism

The Impact of Different Implantation Sites and Sex on the Differentiation of Human Pancreatic Endoderm Cells Into Insulin-Secreting Cells In Vivo

Nelly Saber et al.

Summary: This study investigates the differentiation of human embryonic stem cell-derived pancreatic endoderm cells (PECs) in different implantation sites. It is found that PECs implanted in the TheraCyte device display faster secretion of human C-peptide, while cells implanted under the kidney capsule or in the gonadal fat pad show slower secretion. Interestingly, PECs implanted under the kidney capsule in female mice exhibit faster differentiation to endocrine cells and higher levels of arginine-stimulated glucagon and glucagon-like peptide 1 secretion.

DIABETES (2023)

Article Endocrinology & Metabolism

Residual insulin secretion in individuals with type 1 diabetes in Finland: longitudinal and cross-sectional analyses

Minna Harsunen et al.

Summary: Contrary to the presumption that type 1 diabetes leads to an absolute insulin deficiency, this study found that many individuals with type 1 diabetes still have circulating C-peptide years after diagnosis. The study also identified the correlation between age at diagnosis and decline in C-peptide secretion, as well as the association between polygenic risk scores, clinical factors, and random serum C-peptide concentrations.

LANCET DIABETES & ENDOCRINOLOGY (2023)

Article Surgery

Function and composition of pancreatic islet cell implants in omentum of type 1 diabetes patients

Freya Van Hulle et al.

Summary: The study found that omental implants can help restore metabolic control in type 1 diabetes patients, but it may require a higher number of beta cells in the grafts and elimination of immunogenic non-endocrine components in order to establish a metabolically adequate functional beta cell mass in the omentum.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Article Endocrinology & Metabolism

6. Glycemic Targets: Standards of Medical Care in Diabetes-2022

Summary: The American Diabetes Association provides clinical practice recommendations and tools for evaluating diabetes care quality through their medical care standards. The standards are updated annually and comments are welcome on their professional website.

DIABETES CARE (2022)

Article Surgery

Elevated islet prohormone ratios as indicators of insulin dependency in auto-islet transplant recipients

Yi-Chun Chen et al.

Summary: Pancreatic islet transplantation has therapeutic potential in type 1 diabetes and chronic pancreatitis, but the long-term outcomes are modest. This study analyzed prohormone peptide levels in patients and mouse models of islet transplantation and found that higher proinsulin-to-C-peptide and proIAPP-to-total IAPP ratios were associated with insulin dependency. Histological analysis also revealed altered prohormone processing in failing grafts.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Article Biotechnology & Applied Microbiology

Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells

Diego Balboa et al.

Summary: Transplanting pancreatic islet cells derived from human pluripotent stem cells has great potential for treating diabetes. This study generated functionally mature stem-cell-derived islets (SC-islets) using an optimized protocol and compared them comprehensively to primary adult islets. The results showed that SC-islets exhibited similar functional properties to adult islets in terms of insulin secretion, electrophysiology, signaling, and exocytosis. Additionally, single-cell transcriptomics revealed a continuous maturation trajectory of SC-islets in vitro and during engraftment in mice, closely resembling that of primary islets.

NATURE BIOTECHNOLOGY (2022)

Editorial Material Cell & Tissue Engineering

Stem cell-based islet replacement therapy in diabetes: A road trip that reached the clinic

Eelco J. P. de Koning et al.

Summary: Researchers reported interim results from a multicenter clinical trial showing insulin secretion from engrafted pluripotent stem cell-derived endocrine progenitor cells in patients with type 1 diabetes, marking a significant advancement in diabetes treatment.

CELL STEM CELL (2021)

Article Cell & Tissue Engineering

Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes

Adam Ramzy et al.

Summary: This study evaluates the safety and efficacy of implanting pancreatic endoderm cells for treating type 1 diabetes, showing increased C-peptide levels and mature beta cell phenotype in grafts after implantation. The findings provide evidence of meal-regulated insulin secretion by differentiated stem cells in patients.

CELL STEM CELL (2021)

Article Cell & Tissue Engineering

Microvessels support engraftment and functionality of human islets and hESC-derived pancreatic progenitors in diabetes models

Yasaman Aghazadeh et al.

Summary: This study enhanced islet transplantation by using microvessels from adipose tissue, resulting in improved cell survival and glucose response in both human islets and hESC-derived pancreatic cells, ameliorating preexisting diabetes in three mouse models of T1D.

CELL STEM CELL (2021)

Article Cell Biology

Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device

A. M. James Shapiro et al.

Summary: Preliminary data from a phase 1/2 study show that pluripotent stem cell-derived pancreatic endoderm cells engrafted in type 1 diabetes patients can develop into functional islet cells releasing insulin in a regulated manner. Although engraftment and insulin expression were observed in some subjects, potential adverse events related to surgical implantation or immunosuppression remain a concern.

CELL REPORTS MEDICINE (2021)

Article Medicine, Research & Experimental

High residual C-peptide likely contributes to glycemic control in type 1 diabetes

Michael R. Rickels et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Review Endocrinology & Metabolism

Alpha cell regulation of beta cell function

Tilo Moede et al.

DIABETOLOGIA (2020)

Review Medicine, General & Internal

Advances in β-cell replacement therapy for the treatment of type 1 diabetes

Marie-Christine Vantyghem et al.

LANCET (2019)

Editorial Material Endocrinology & Metabolism

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

Richard M. Bergenstal et al.

DIABETES CARE (2018)

Review Pharmacology & Pharmacy

Do glucagon-like peptide-1 receptor (GLP-1R) agonists have potential as adjuncts in the treatment of type 1 diabetes?

Sheila A. Doggrell

EXPERT OPINION ON PHARMACOTHERAPY (2018)

Review Endocrinology & Metabolism

Clinical pancreatic islet transplantation

A. M. James Shapiro et al.

NATURE REVIEWS ENDOCRINOLOGY (2017)

Letter Medicine, General & Internal

Bioengineering of an Intraabdominal Endocrine Pancreas

David A. Baidal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Multidisciplinary Sciences

Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sites

Jessica D. Weaver et al.

SCIENCE ADVANCES (2017)

Article Endocrinology & Metabolism

Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia

Bernhard J. Hering et al.

DIABETES CARE (2016)

Article Biotechnology & Applied Microbiology

A prevascularized subcutaneous device-less site for islet and cellular transplantation

Andrew R. Pepper et al.

NATURE BIOTECHNOLOGY (2015)

Article Endocrinology & Metabolism

Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts

Evi Motte et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)

Article Biochemistry & Molecular Biology

Generation of Functional Human Pancreatic β Cells In Vitro

Felicia W. Pagliuca et al.

Article Biotechnology & Applied Microbiology

Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells

Alireza Rezania et al.

NATURE BIOTECHNOLOGY (2014)

Article Multidisciplinary Sciences

Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graft

Bart Keymeulen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Biotechnology & Applied Microbiology

Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells

Kevin A. D'Amour et al.

NATURE BIOTECHNOLOGY (2006)

Article Endocrinology & Metabolism

beta-cell function following human islet transplantation for type 1 diabetes

MR Rickels et al.

DIABETES (2005)

Article Medicine, General & Internal

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

AMJ Shapiro et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)